Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07MNT
|
|||
| Former ID |
DIB000051
|
|||
| Drug Name |
P52-/p36- GAP vaccine
|
|||
| Synonyms |
P52-/p36- GAP vaccine (malaria); P52-/p36-GAP vaccine (malaria), Seattle Biomedical Research Institute/Walter Reed; P52-/p36-vaccine (Genetically Attenuated Parasite, malaria), Seattle Biomedical Research Institute/Walter Reed
Click to Show/Hide
|
|||
| Indication | Malaria [ICD-11: 1F40-1F45; ICD-10: B50-B64, B54] | Phase 1/2 | [1] | |
| Company |
Seattle Biomedical Research Institute
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01024686) Phase 1/2a Trial of Pf GAP p52-/p36- Sporozoite Malaria Vaccine. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.